Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Clinical trial NCT02118584 · TERMINATED
Trial details
- NCT number
- NCT02118584
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2023-10-05
- Enrollment
- 1822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.